Stevanato Group S.p.A.: Stevanato Group Reports Second Quarter 2022 Financial Results
- Raises Fiscal 2022 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and
Source: finanznachrichten.de